longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Caredex

CDNA

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 25.31, above the reasonable range, cheaper than 0.77% of the time in the past 1 years, and the industry ranks 44/602, the industry Median -2.33.

25.31xP/E
$54.31Stock price
$2.15Earnings per share
25.31xP/E
Stock price$54.31Earnings per share$2.15

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
13.00x
Typical range
-135.20x–14.91x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
019385776

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
AMGNUSAmgen
25.11x11.27%$219.55B
VRTXUSVertex Pharma
29.71x36.49%$130.87B
REGNUSRegeneron Pharma
19.07x5.79%$82.55B
INCYUSIncyte
15.67x65.04%$25.26B
GMABUSGenmab A/S
27.12x24.93%$21.37B
UTHRUSUnited Therap
16.01x6.43%$20.99B
ASNDUSAscendis Pharmac
17.05x477.43%$14.68B
NBIXUSNeurocrine Biosciences
20.10x50.16%$14.18B
EXELUSExelixis
16.33x16.46%$14.06B
TGTXUSTG Therap
19.42x65.83%$8.57B
CDNAUSCaredex
25.31x629.58%$2.81B
KMDAUSKamada
22.74x39.29%$506.12M
PBYIUSPuma BioTech
17.93x37.70%$479.03M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.